CoChat

Study of blood linear RNA nominates CD55 and DLD as early-stage biomarkers for Parkinson's disease

Open access

The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.

Abstract

Parkinson's disease (PD) is the second leading neurodegenerative disease, pathologically characterized by the accumulation of alpha-synuclein in the brain and the loss of dopaminergic neurons in the substantia nigra pars compacta. Despite the intensive efforts to identify diagnostic biomarkers for PD and nominating prospective candidates such as such as CSF α-synuclein seed amplification assay or α-/β-synuclein ratio, establishment of minimally invasive biomarkers remains the focus of PD research. We leveraged transcriptomic data from 4343 participants from four independent datasets to robustly identify PD-associated transcripts. Following the differential abundance analyses, we integrated our findings with several brain transcriptomic, CSF proteomic, plasma proteomic and genomic data to add biological context. We further leveraged our findings to develop predictive models that could differentiate between PD and healthy controls. We identified 296 differentially expressed transcripts, 28 of which were transcribed from known PD-associated loci. Furthermore, we found a significant overlap between our findings and transcripts dysregulated in brain, as well as proteins that differentially accumulate in CSF. Our results suggested that expression of the identified transcripts was affected by genetic background, including ancestry and PD-related mutations, and nearly half of the identified transcripts were dysregulated before symptom onset. The differentially expressed transcripts were utilized to develop three predictive models that distinguished PD from healthy controls with an area under the receiver operating characteristic curve of 0.727–0.733. The predictive models detected transcriptomic PD signatures even before symptom onset. Overall, two transcripts, DLD and CD55, showed particular promise as early stage, minimally invasive PD biomarkers. DLD was significantly related to PD in the expression quantitative trait loci (eQTL) analyses, and we identified a putative eQTL for CD55. Their protein products differentially accumulated in CSF, and both DLD and CD55 were included in all three predictive models. Having performed the largest transcriptomic study of PD to date, we demonstrate that the transcriptome can be leveraged to develop minimally invasive biomarkers that may aid in diagnosing the disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awag014

Cites

89 of 89 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Nalls, 2019, Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: A meta-analysis of genome-wide association studies, Lancet Neurol, 18, 1091, 10.1016/S1474-4422(19)30320-5 · DOI · Paper page

Cited by

See all 2

Metadata

Authors
Beric, A., Sahin, S., Sanchez, S., Yang, Z., Kumar, R., Alfradique-Dunham, I., Sanford, J., Western, D., Phillips, B., Budde, J. P., Perrin, R. J., Kotzbauer, P. T., Perlmutter, J. S., Norris, S. A., Cruchaga, C., & Ibanez, L.
Affiliations
  • Washington University in St. Louis (US)
  • Department of Neurology, Washington University in Saint Louis School of Medicine , St.Louis, MO 63110 ,
  • Department of Psychiatry, Washington University in Saint Louis School of Medicine , St.Louis, MO 63110 ,
Venue
Brain
Published
2026-01-13
Volume
149
Issue
10
Pages
3509-3523
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W7123868984
Cited by
2
References
85
Citations by year
2026: 2
FWCI
8.50
Type
journal article
Language
en
Open access
Locations
  • Brain (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
Funders
  • Department of Defense (W81XWH2010849)
  • Bright Focus Foundation (A2021033S)
  • Michael J. Fox Foundation (MJFF-021599)
  • National Institutes of Health (P30AG066444, R00AG062723, U19AG03243812, R01AG053267, RF1NS075321)
  • Alzheimer’s Association (DIAN-TU-PP-22-872356, DIANTUOLE21725093)
  • American Parkinson Disease Association
  • the Barnes-Jewish Hospital Foundation
  • Paula and Rodger Riney Fund
  • NGI Pilot Grant
Topics
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Parkinson's disease, blood transcriptome, CD55, DLD, minimally invasive biomarkers, differential gene expression, CSF proteomics, plasma proteomics, genetic ancestry, genetic variants, prediction model, alpha-synuclein, expression quantitative trait loci
MeSH terms
Aged, Female, Humans, Male, Middle Aged, Parkinson Disease, RNA, Biomarkers, CD55 Antigens, Proteomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.